Serina Therapeutics registers 12.5 million shares for Roth Principal Investments resaleAug 24FinancingSerina Therapeutics
Supernus and Indivior agree to merge as Supernus reports second-quarter growthAug 3Quarterly updateSupernus Pharmaceuticals, Inc.
Sign inSign in